-
1
-
-
0035654409
-
Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia
-
Rozen TD. Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia. Headache. 2000;41:S25-S32.
-
(2000)
Headache
, vol.41
-
-
Rozen, T.D.1
-
2
-
-
0029922472
-
The long-term outcome of microvascular decompression for trigeminal neuralgia
-
Barker FG II, Jannetta PJ, Bissonette DJ, et al. The long-term outcome of microvascular decompression for trigeminal neuralgia. N Engl J Med. 1996;334:1077-1083.
-
(1996)
N Engl J Med
, vol.334
, pp. 1077-1083
-
-
Barker II, F.G.1
Jannetta, P.J.2
Bissonette, D.J.3
-
3
-
-
50549189257
-
Trigeminal neuralgia: Its treatment with a new anti-convulsant drug (G-32883)
-
Blom S. Trigeminal neuralgia: its treatment with a new anti-convulsant drug (G-32883). Lancet. 1962;i:839-840.
-
(1962)
Lancet
, vol.1
, pp. 839-840
-
-
Blom, S.1
-
4
-
-
0035904760
-
1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials
-
1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358:1668-1675.
-
(2001)
Lancet
, vol.358
, pp. 1668-1675
-
-
Ferrari, M.D.1
Roon, K.I.2
Lipton, R.B.3
-
5
-
-
0025816337
-
The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan
-
Fowler PA, Lacey LF, Thomas M, et al. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan. Eur Neurol. 1991;31:291-294.
-
(1991)
Eur Neurol
, vol.31
, pp. 291-294
-
-
Fowler, P.A.1
Lacey, L.F.2
Thomas, M.3
-
6
-
-
0031898120
-
Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, 100 mg) in the acute treatment of migraine: Defining the optimum doses of oral supatriptan
-
Pfaffenrath V, Cunin G, Sjonell G, et al. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, 100 mg) in the acute treatment of migraine: defining the optimum doses of oral supatriptan. Headache. 1998;38:184-190.
-
(1998)
Headache
, vol.38
, pp. 184-190
-
-
Pfaffenrath, V.1
Cunin, G.2
Sjonell, G.3
-
7
-
-
33749205615
-
A double-blind placebo-controlled study assessing the efficacy and tolerability of 50mg sumatriptan tablets in the acute treatment of migraine
-
Sumatriptan Tablets S2CM07 Study Group
-
Savani N, Brautaset NJ, Reunanen M, et al. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group. Int J Clin Pract. 1999;105(Suppl):7-15.
-
(1999)
Int J Clin Pract
, vol.105
, Issue.SUPPL.
, pp. 7-15
-
-
Savani, N.1
Brautaset, N.J.2
Reunanen, M.3
-
8
-
-
0036850382
-
1A receptor activation: A new mechanism of profound central analgesia
-
1A receptor activation: a new mechanism of profound central analgesia. Neuropharmacology. 2002;43:945-958.
-
(2002)
Neuropharmacology
, vol.43
, pp. 945-958
-
-
Colpaert, F.C.1
Tarayre, J.P.2
Koek, W.3
-
9
-
-
0029813854
-
Differential expression of sumatriptan-sensitive 5-hydroxy-tryptamine receptors in human trigeminal ganglia and cerebral blood vessels
-
Bouchelet I, Cohen Z, Case B, et al. Differential expression of sumatriptan-sensitive 5-hydroxy-tryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol. 1996;50:219-223.
-
(1996)
Mol Pharmacol
, vol.50
, pp. 219-223
-
-
Bouchelet, I.1
Cohen, Z.2
Case, B.3
-
10
-
-
0035063723
-
An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system
-
Limmroth V, Katsarava Z, Liedert B, et al. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain. 2001;92:101-106.
-
(2001)
Pain
, vol.92
, pp. 101-106
-
-
Limmroth, V.1
Katsarava, Z.2
Liedert, B.3
-
11
-
-
0024379698
-
Percutaneous injection of glycerol for the treatment of trigeminal neuralgia
-
Waltz TA, Dalessio DJ, Copeland B, et al. Percutaneous injection of glycerol for the treatment of trigeminal neuralgia. Clin J Pain. 1989;5:195-198.
-
(1989)
Clin J Pain
, vol.5
, pp. 195-198
-
-
Waltz, T.A.1
Dalessio, D.J.2
Copeland, B.3
-
12
-
-
0027054718
-
Glycerol injection to the rat trigeminal nerve: Histological and immunohistochemical studies
-
Hara H, Kobayashi S. Glycerol injection to the rat trigeminal nerve: histological and immunohistochemical studies. Acta Neurochir (Wien). 1992;119:111-114.
-
(1992)
Acta Neurochir (Wien)
, vol.119
, pp. 111-114
-
-
Hara, H.1
Kobayashi, S.2
-
13
-
-
0023684179
-
Enrichment of a vasoactive neuropeptide (calcitonin gene-related peptide) in the trigeminal sensory projection to the intracranial arteries
-
O'Connor TP, van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene-related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci. 1988;8:2468-2476.
-
(1988)
J Neurosci
, vol.8
, pp. 2468-2476
-
-
O'Connor, T.P.1
Van Der Kooy, D.2
-
14
-
-
0022347682
-
Calcitonin gene-related peptide is a potent inhibitor of substance P degradation
-
Le Greves P, Nyberg F, Terenius L, et al. Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur J Pharmacol. 1985;115:309-311.
-
(1985)
Eur J Pharmacol
, vol.115
, pp. 309-311
-
-
Le Greves, P.1
Nyberg, F.2
Terenius, L.3
-
15
-
-
0023143665
-
Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats
-
Oku R, Satoh M, Fujii N, et al. Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res. 1987;403:350-354.
-
(1987)
Brain Res
, vol.403
, pp. 350-354
-
-
Oku, R.1
Satoh, M.2
Fujii, N.3
-
16
-
-
0023874663
-
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
-
Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 1988;23:193-196.
-
(1988)
Ann Neurol
, vol.23
, pp. 193-196
-
-
Goadsby, P.J.1
Edvinsson, L.2
Ekman, R.3
-
17
-
-
0030987440
-
Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia
-
Strittmatter M, Grauer M, Isenberg E, et al. Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache. 1997;37:211-216.
-
(1997)
Headache
, vol.37
, pp. 211-216
-
-
Strittmatter, M.1
Grauer, M.2
Isenberg, E.3
-
18
-
-
0035207990
-
Trigeminal neuralgia: Pathology and pathogenesis
-
Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain. 2001;124:2347-2360.
-
(2001)
Brain
, vol.124
, pp. 2347-2360
-
-
Love, S.1
Coakham, H.B.2
|